Seeking Alpha

Celgene's (CELG) board authorizes the repurchase of an additional $2.5B of the pharmaceutical...

Celgene's (CELG) board authorizes the repurchase of an additional $2.5B of the pharmaceutical company's shares, which it will carry out in the open market or in privately negotiated transactions from time to time. (PR)
Comments (1)
  • bigazul
    , contributor
    Comments (963) | Send Message
     
    They would do allot more for their shares if they began a dividend.
    13 Jun 2012, 02:27 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|